TRRAP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.836420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.730800E-01
Normal-vs-Stage2
1.615570E-01
Normal-vs-Stage3
1.799420E-01
Normal-vs-Stage4
5.517000E-01
Stage1-vs-Stage2
4.141000E-01
Stage1-vs-Stage3
4.122400E-02
Stage1-vs-Stage4
9.608600E-01
Stage2-vs-Stage3
1.820640E-03
Stage2-vs-Stage4
5.361000E-01
Stage3-vs-Stage4
1.050490E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.016000E-01
Normal-vs-AfricanAmerican
4.777600E-01
Normal-vs-Asian
1.148620E-01
Caucasian-vs-AfricanAmerican
6.019600E-01
Caucasian-vs-Asian
3.611800E-01
AfricanAmerican-vs-Asian
2.429800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.950100E-02
Normal-vs-Female
3.186400E-01
Male-vs-Female
4.032200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.830000E-01
Normal-vs-Age(41-60Yrs)
5.849200E-01
Normal-vs-Age(61-80Yrs)
4.938300E-02
Normal-vs-Age(81-100Yrs)
3.040200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.026000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.212300E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.786300E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.902000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.101800E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.687000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.012400E-02
Normal-vs-Daily Drinker
3.171000E-01
Normal-vs-Weekly Drinker
9.316200E-02
Normal-vs-Occasional Drinker
7.234800E-01
Normal-vs-Social Drinker
5.478000E-01
Non Drinker-vs-Daily Drinker
5.579600E-01
Non Drinker-vs-Weekly Drinker
9.885600E-01
Non Drinker-vs-Occasional Drinker
2.295000E-01
Non Drinker-vs-Social Drinker
7.560400E-02
Daily Drinker-vs-Weekly Drinker
5.977000E-01
Daily Drinker-vs-Occasional Drinker
1.480820E-01
Daily Drinker-vs-Social Drinker
6.017600E-02
Weekly Drinker-vs-Occasional Drinker
2.488600E-01
Weekly Drinker-vs-Social Drinker
1.558040E-01
Occasional Drinker-vs-Social Drinker
9.319000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.464590E-01
Normal-vs-Grade 2
1.589700E-02
Normal-vs-Grade 3
1.168420E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.491800E-01
Grade 1-vs-Grade 3
7.041400E-01
Grade 1-vs-Grade 4
1.464590E-01
Grade 2-vs-Grade 3
5.243900E-02
Grade 2-vs-Grade 4
1.589700E-02
Grade 3-vs-Grade 4
1.168420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.521800E-01
Normal-vs-NonDiabetic
2.208200E-01
Diabetic-vs-NonDiabetic
1.719410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.173600E-01
Normal-vs-NoPancreatitis
1.897210E-01
Pancreatitis-vs-NoPancreatitis
8.666000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.689020E-01
Normal-vs-N1
1.915970E-01
N0-vs-N1
7.287800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.801000E-01
Normal-vs-TP53-NonMutant
4.081600E-01
TP53-Mutant-vs-TP53-NonMutant
5.751400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
